Gemcitabine/nab-paclitaxel as second-line therapy following FOLFIRINOX in metastatic/advanced pancreatic cancer- retrospective analysis of response

Khanh T. Nguyen, Aparna Kalyan, H. Scott Beasley, Aatur D. Singhi, Weijing Sun, Herbert J. Zeh, Daniel Normolle, Nathan Bahary

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Gemcitabine/nab-paclitaxel as second-line therapy following FOLFIRINOX in metastatic/advanced pancreatic cancer- retrospective analysis of response'. Together they form a unique fingerprint.

Medicine & Life Sciences